Skip to main content
. 2023 Jun 27;66(3):E310–E320. doi: 10.1503/cjs.017020

Fig. 2.

Fig. 2

Kaplan–Meier overall survival estimates (A) overall, (B) stratified by International Federation of Obstetrics and Gynecology (FIGO) stage, (C) stratified by residual disease after cytoreductive surgery, (D) stratified by treatment with platinum-based chemotherapy (chemo), (E) stratified by treatment with platinum-based chemotherapy in patients with stage I disease and (F) stratified by race.